Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.63 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | GSK3B | P49841 | 8/20 | 0.54 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4500697 | 0.89 | GSK3B (0.67) | HDAC6HDAC1HDAC2HDAC8GSK3B | |
| SCHEMBL4496581 | 0.85 | HDAC1 (0.65) | HDAC6HDAC1HDAC2HDAC8GSK3B | |
| SCHEMBL4492565 | 0.83 | HDAC1 (0.57) | HDAC6HDAC1HDAC2HDAC8GSK3B | |
| SCHEMBL4490865 | 0.83 | HDAC1 (0.73) | HDAC6HDAC1HDAC2HDAC8GSK3B | |
| SCHEMBL4497413 | 0.83 | HDAC1 (0.73) | HDAC6HDAC1HDAC2HDAC8GSK3B | |
| SCHEMBL4500710 | 0.83 | HDAC1 (0.62) | HDAC6HDAC1HDAC2HDAC8GSK3B | |
| SCHEMBL1461499 | 0.82 | HDAC1 (0.78) | HDAC1HDAC2HDAC8GSK3B | |
| SCHEMBL4494131 | 0.81 | HDAC6 (0.71) | HDAC6HDAC1HDAC2HDAC8GSK3B | |
| SCHEMBL4502900 | 0.81 | GSK3B (0.58) | HDAC6HDAC1HDAC2HDAC8ALDH1A1 | |
| SCHEMBL4503653 | 0.81 | HDAC1 (0.65) | HDAC6HDAC1HDAC2HDAC8GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632854-B2 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PFIZER ITALIA S.R.L. (IT) | 2009-12-15 | — | — | US | claimed |